CAS: 13349-91-2; 1-(2,2,2-Trifluoroethyl)Piperazine Dihydrochloride

该化合物是一种化学化合物,其特征是其管子子核心,是六人组成的环环环矿,三氟乙基组的存在增加了其亲脂性并可能影响其生物活动.作为盐盐,它通常在水中更容易溶解,这有利于各种应用,包括药物.三氟乙基子子基体可产生独特的特性,如代谢稳定性提高和药用植物改变.该化合物可能具有作为制药剂的潜力,特别是在开发针对...

结构式图片

相似化合物

13349-90-1 245487-45-0 692058-21-2

欧盟法规

C&L通报

上下游产品

CAS号692058-21-2 1-B°C-4-(2,2,2-... | CAS号13349-90-1 1-(2,2,2-三氟乙基)哌嗪

合成工艺路线路线简述

    📜盐酸,4-(2,2,2-三氟乙基)哌嗪-1-羧酸叔丁酯 以 1,4-二氧六环 用作溶剂,化学反应 3.0H,以to Yield 1-(2,2,2-Trifluoroethyl)Piperazine Dihydrochloride (0.631 G,95%) As A White Solid的收率获得1-(2,2,2-三氟乙基)哌嗪二盐酸盐
    参考文献:Chiral Cis-Imidazolines
    标题:Chiral Cis-Imidazolines
    摘要:"and The Pharmaceutically Acceptable Salts And Esters Thereof,Wherein X1,X2,X3,Y1,Y2And R Are Described Herein Inhibit The Interaction Of Mdm2 Protein With A P53-Like Peptide And Hence Have Anti Proliferative Activity." 翻译成中文为:"其中x1,X2,X3,Y1,Y2和r所描述的药物可接受的盐和酯类物质,能够抑制mdm2蛋白与p53样肽的相互作用,从而具有抗增殖活性."

    海关参考信息

    专利信息


    专利号:US-11325903-B2
    优先权日:2016-11-30
    标 题:Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
    发明人:SIDDIQUI M ARSHAD; CIBLAT STEPHANE; DERY MARTIN; CONSTANTINEAU-FORGET LEA; GRAND-MAITRE CHANTAL; BRUNEAU-LATOUR NICOLAS; SHIPPS GERALD W; COOPER ALAN B; OZA VIBHA; KOSTURA MATTHEW J; LUTHER MICHAEL; LEVINE JEDD
    权利人:BANTAM PHARMACEUTICAL LLC
    摘要:Disclosed are compounds useful, for example, in methods of treating hyperproliferative disorders such as cancer, methods of arresting the cell cycle in cancer cells, methods of inhibiting glutathione synthesis in cancer cells, and associated compounds for use and uses in medicaments. In certain embodiments, the methods, uses and compounds are provided with reference to compounds of the structural formulae (Ia), (Ib), (Ic), (Id) and (Ie), in which R 1 , L 1 , L 2 , Q, L 3 , R 3 , L 4 , R 4 , L 5 , and R 5 are as described herein. In certain embodiments, compounds disclosed herein are especially active against cancers having a mutant KRAS gene.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知